In May, Discern Health Director Theresa Schmidt moderated two panels that built on the discussion presented in the National Pharmaceutical Council (NPC) and Discern white paper, Improving Patient-reported Measures in Oncology.
The panels at the annual meetings of the Pharmacy Quality Alliance (PQA) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) discussed gaps in patient-reported measures (PRMs) in oncology and examined controversies on this topic from multiple perspectives. PRMs are tools, such as surveys, that capture patients’ voices related to their care. Patient-reported performance measures (PR-PMs) translate PRM responses into metrics that can be used to assess provider performance, compare entities, and measure changes over time.
For more information, please contact Theresa Schmidt at firstname.lastname@example.org.